SOURCE: Emergent Health Corp.

April 30, 2008 08:05 ET

Emergent Health Corp. Announces Release of a Very Positive Independent Research Report

Highlights: Corporate's Knowledge of Compounding, Nutrition, Biochemistry and Advanced Research Technology; Management's Understanding of the Nutraceutical Discovery Process and Proven Marketing Expertise in Marketing Biotechnology Products; Executives Have Advanced the Lead Products From Early Development to Commercialization; Positioning of Emergent as an Important Player in the Anti-Aging, Weight Loss and the Lifestyle Nutraceutical Market

MYRTLE BEACH, SC--(Marketwire - April 30, 2008) - Emergent Health Corp. (PINKSHEETS: EMGN), which is a biotechnology company engaged in the research and development, marketing and sale of lifestyle, dietary supplements and drugs, today is pleased to announce the positive results of the Independent Research Report (the "Research Report") authored by the independent research firm, Ana Pastorfide.

EMGN Research Report - To view the research report please visit the following link:

http://0301.netclime.net/1_5/295/193/37d/Ana%20Pastorfide%20Emergent%20Health%20Corp.%20Revised%20Report.pdf

About Emergent Health Corp:

Emergent Health Corp. (PINKSHEETS: EMGN) is a company focused on providing a better health and lifestyle through natural products. Emergent Health Corp.'s flagship products include Hungarest™, a diet aid, a proprietary patent-pending formulation having the unique ability to control appetite both in the stomach and brain. These two mechanisms, acting together, have a cumulative effect greater than any one appetite control mechanism. There is also evidence that the mechanisms continue to exert an effect after the goal weight is attained and the Hungarest™ diet aid is discontinued. (www.emergenthealth.com) (www.vita-stim.com) (www.appetitecontrolled.com)

Vita-Stim™, a life-enhancement supplement, is a proprietary patent-pending formulation with the ability to improve the immune system, as well as stimulate stem cells from each consumer's own body mechanism in their bone marrow. There is mounting evidence that a dual acting mechanism can have a positive effect upon many known human conditions.

EMGN also has exciting new products currently in research and development. They continue to develop highly sought after safe and natural remedies to medical issues affecting a large segment of U.S. consumers:

1.   A product for Erectile Dysfunction known in-house as ERDEX.
2.   A product for Peyronies Disease known in-house as PX.
3.   A product designed to enhance hair growth known in-house as Hair-Gain.

About Ana Pastorfide

Ana Pastorfide (AP) is an independent research firm specializing in small and micro capitalization companies. AP has no investment banking or consultation conflicts thus minimizing the conflicts of interest between the research analysts and the companies they cover. AP is not a registered investment advising firm, nor broker dealer.

This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

Contact Information